Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-03-06 @ 12:59 PM
Study NCT ID:
NCT00003466
Status:
COMPLETED
Last Update Posted:
2014-07-09
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Sponsor:
Duke University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain and Central Nervous System Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent adult brain tumor | View |
| None | adult mixed glioma | View |
| None | childhood mixed glioma | View |
| None | adult pilocytic astrocytoma | View |
| None | adult subependymoma | View |
| None | recurrent childhood cerebral astrocytoma | View |
| None | adult brain stem glioma | View |
| None | recurrent childhood brain stem glioma | View |
| None | untreated childhood brain stem glioma | View |
| None | recurrent childhood visual pathway and hypothalamic glioma | View |
| None | untreated childhood visual pathway and hypothalamic glioma | View |
| None | adult oligodendroglioma | View |
| None | adult diffuse astrocytoma | View |